Human Platelet Lysate (hPL) is a solution obtained by lysing human platelets. It contains a rich mix of growth factors, cytokines and other bioactive molecules that stimulate cell growth, regeneration and tissue repair. This makes it ideally suited as a xeno-free supplement for (stem) cell culture in cell therapy production, among others.
hPL is made from exclusively human material, thus no animal products are involved. This not only increases compatibility with human cell culture but eliminates the risk of zoonotic infections as with FBS. When ultimately used for clinical purposes, there is no risk of patient immunisation against animal proteins and is an additional argument to the regulator for approving your cultured cells.
Choosing hPL over FBS is also recommended for research groups. Not only is hPL often more efficient than FBS, it is, above all, an important choice for the long term of your project. When translating to a clinical setting by you or third parties, the use of FBS during research is a distinct disadvantage as it necessitates a switchover from FBS to hPL. As a result, your costly research must be re-lined with hPL.
This product has met the following criteria to qualify for the following awards: